BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33864522)

  • 1. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
    Cheng Y; Qin SK; Li J; Dai GH; Shen BY; Ying JE; Ba Y; Liang H; Wang XB; Xu Y; Zhou L; Ding KF; Qin YR; Yang SJ; Guan WX; Zheng H; Wang Q; Song H; Zhu YP
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):673-684. PubMed ID: 33864522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts.
    Xu H; Zheng H; Zhang Q; Song H; Wang Q; Xiao J; Dong Y; Shen Z; Wang S; Wu S; Wei Y; Lu W; Zhu Y; Niu X
    Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e48-e59. PubMed ID: 35781406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsy.
    Zhuang YP; Zhu YP; Wang HY; Sun L; Zhang J; Hao YP; Wang L
    Braz J Med Biol Res; 2017 May; 50(6):e6000. PubMed ID: 28538836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathways.
    Tabbò F; Guerrera F; van den Berg A; Gaudiano M; Maletta F; Bessone L; Nottegar A; Costardi L; de Wijn R; Ruijtenbeek R; Delsedime L; Sapino A; Ruffini E; Hilhorst R; Inghirami G
    Eur J Cancer; 2021 Feb; 144():17-30. PubMed ID: 33316635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer.
    Hidalgo M; Bruckheimer E; Rajeshkumar NV; Garrido-Laguna I; De Oliveira E; Rubio-Viqueira B; Strawn S; Wick MJ; Martell J; Sidransky D
    Mol Cancer Ther; 2011 Aug; 10(8):1311-6. PubMed ID: 21673092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
    PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer.
    Zhu M; Jia N; Nie Y; Chen J; Jiang Y; Lv T; Li Y; Yao L; Feng W
    Int J Gynecol Cancer; 2018 Nov; 28(9):1812-1820. PubMed ID: 30358704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.
    Zhu Y; Tian T; Li Z; Tang Z; Wang L; Wu J; Li Y; Dong B; Li Y; Li N; Zou J; Gao J; Shen L
    Sci Rep; 2015 Feb; 5():8542. PubMed ID: 25712750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
    Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
    Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer].
    Qin B; Jiao X; Yuan L; Liu K; Zang Y
    Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):715-719. PubMed ID: 29061220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of the PDTX model of gynecological tumors.
    Yang W; Fan WS; Ye MX; Li Z; Gu CL; Zhu YP; Hao YP; Wang ZQ; Wang L; Meng YG
    Am J Transl Res; 2019; 11(6):3779-3789. PubMed ID: 31312388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction.
    Deng Z; Guo T; Bi J; Wang G; Hu Y; Du H; Zhou Y; Jia S; Xing X; Ji J
    J Transl Med; 2023 Sep; 21(1):638. PubMed ID: 37726803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.
    Monsma DJ; Cherba DM; Richardson PJ; Vance S; Rangarajan S; Dylewski D; Eugster E; Scott SB; Beuschel NL; Davidson PJ; Axtell R; Mitchell D; Lester EP; Junewick JJ; Webb CP; Monks NR
    Pediatr Blood Cancer; 2014 Sep; 61(9):1570-7. PubMed ID: 24687871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful establishment of patient-derived tumor xenografts from gastrointestinal stromal tumor-a single center experience.
    Jiang Q; Tong HX; Zhang Y; Hou YY; Li JL; Wang JY; Zhou YH; Lu WQ
    Am J Cancer Res; 2016; 6(2):533-43. PubMed ID: 27186422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a non-small-cell lung cancer-liver metastasis patient-derived tumor xenograft model for the evaluation of patient-tailored chemotherapy.
    Yang X; Meng G
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current research developments of patient-derived tumour xenograft models (Review).
    Yin Z; Maswikiti EP; Liu Q; Bai Y; Li X; Qi W; Liu L; Ma Y; Chen H
    Exp Ther Med; 2021 Nov; 22(5):1206. PubMed ID: 34584551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.
    Monsma DJ; Monks NR; Cherba DM; Dylewski D; Eugster E; Jahn H; Srikanth S; Scott SB; Richardson PJ; Everts RE; Ishkin A; Nikolsky Y; Resau JH; Sigler R; Nickoloff BJ; Webb CP
    J Transl Med; 2012 Jun; 10():125. PubMed ID: 22709571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery.
    Cacciapuoti MT; Cappelli LV; Fiore D; Toruno P; Kayembe C; Tam W; Inghirami G
    Curr Protoc; 2021 Apr; 1(4):e96. PubMed ID: 33861502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
    Yang CY; Lin CK; Hsieh CC; Tsao CH; Lin CS; Peng B; Chen YT; Ting CC; Chang WC; Lin GJ; Sytwu HK; Chen YW
    Head Neck; 2019 May; 41(5):1260-1269. PubMed ID: 30537218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.